Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/3383
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBATABYAL, S. K.-
dc.contributor.authorMAJHI, R.-
dc.contributor.authorBASU, P. S.-
dc.date.accessioned2019-06-26T04:23:07Z-
dc.date.available2019-06-26T04:23:07Z-
dc.date.issued2009-
dc.identifier.uri10.4149/neo_2009_01_68-
dc.identifier.urihttp://172.16.0.4:8085/heritage/handle/123456789/3383-
dc.description.abstractThe present investigation was a lectin-based diagnosis of malignant prostate cancer (PC) by the interaction of phytohemagglutinin (PHA lectin) from Phaseolus vulgaris with the glycan part of serum prostate specific antigen (PSA ) of patients with prostatic disorder. This was confirmed by the interaction between PHA and purified PSA obtained from serum by electrophoretic separation and finally by HPL C chromatography. The precipitate of carbohydrate content after binding of PHA with purified PSA of PC was significantly higher than that of benign prostate hyperplasia (BPH) and/or normal serum PSA . The results suggest that there may be a striking difference in glycosylation pattern of PSA between BPH and PC. The cut off value ≥ 10 μg/ml of the carbohydrate content of PHA-PSA precipitate indicates strong suspicion for PC irrespective of total serum PSA cut off level ≥ 4.0ng/ml by conventional immunoassay method and this may be taken as a guideline in differentiating PC and BPH.en_US
dc.language.isoenen_US
dc.relation.ispartofseriesVol. 56;No. 1-
dc.subjectProstate Canceren_US
dc.subjectBPHen_US
dc.subjectPSAen_US
dc.subjectLectinen_US
dc.titleClinical utility of the interaction between lectin and serum prostate specific antigen in prostate canceren_US
dc.title.alternative(In) Neoplasmaen_US
dc.typeArticleen_US
Appears in Collections:Biotechnology (Publications)

Files in This Item:
File Description SizeFormat 
Clinical utility of the interaction between lectin and serum prostate.pdf37.68 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.